Gano Kyle (CIK 0001567160)

Latest company ownership

Shares held
613
Last filed at
Nov 4, 2025
Confidence Score
51.9
2025Q4
Confidence Score History
2017Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 1, 2025 Nov 4, 2025 NEUROCRINE BIOSCIENCES INC CEO Sell 53.8 -300 -0.21% ✓ $42.6K
Feb 13, 2025 Feb 14, 2025 NEUROCRINE BIOSCIENCES INC CEO Sell 45.0 -2,558 -0.91% ✓ $298.9K
Feb 8, 2025 Feb 12, 2025 NEUROCRINE BIOSCIENCES INC CEO Sell 47.5 -980 -0.71% ✓ $116K
Jan 31, 2025 Feb 4, 2025 NEUROCRINE BIOSCIENCES INC CEO Sell 45.0 -1,541 -1.11% ✓ $235.6K
Jan 15, 2025 Jan 17, 2025 NEUROCRINE BIOSCIENCES INC CEO Sell 13.8 -65,000 -19.36% ✓ $9.2M
Feb 13, 2024 Feb 15, 2024 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 47.5 -1,352 -0.99% ✓ $179.7K
Feb 6, 2024 Feb 8, 2024 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -2,580 -0.96% ✓ $359K
Jan 31, 2024 Feb 2, 2024 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -1,541 -1.16% ✓ $216.8K
Jan 2, 2024 Jan 4, 2024 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 8.8 -75,000 -22.35% ✓ $9.9M
Aug 21, 2023 Aug 23, 2023 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -2,132 -1.61% ✓ $229K
Feb 6, 2023 Feb 8, 2023 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 32.5 -17,004 -3.39% ✓ $1.7M
Jan 31, 2023 Feb 2, 2023 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -1,541 -1.35% ✓ $169.5K
Feb 7, 2022 Feb 9, 2022 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 42.5 -6,880 -1.25% ✓ $554.6K
Jan 5, 2022 Jan 7, 2022 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 10.0 -28,266 -21.21% ✓ $2.4M
Feb 5, 2021 Feb 9, 2021 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 42.5 -6,370 -1.23% ✓ $736.7K
Nov 12, 2020 Nov 16, 2020 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -2,257 -2.25% ✓ $204.8K
Aug 5, 2020 Aug 7, 2020 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 38.8 -2,257 -2.30% ✓ $268.3K
Apr 24, 2020 Apr 28, 2020 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -1,934 -2.02% ✓ $192.4K
Feb 7, 2020 Feb 11, 2020 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -1,623 -1.73% ✓ $167.7K
Feb 5, 2020 Feb 7, 2020 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 42.5 -4,690 -1.30% ✓ $481.7K
Feb 6, 2019 Feb 8, 2019 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 47.5 -762 -0.88% ✓ $63.7K
Feb 4, 2019 Feb 6, 2019 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 42.5 -3,809 -1.14% ✓ $335.7K
Aug 1, 2018 Aug 3, 2018 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 5.0 -28,266 -26.41% ✓ $3.3M
Mar 5, 2018 Mar 7, 2018 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 10.0 -23,650 -23.10% ✓ $2.1M
Feb 5, 2018 Feb 7, 2018 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 45.0 -2,704 -1.14% ✓ $224.2K
Jan 16, 2018 Jan 18, 2018 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -1,625 -2.12% ✓ $128.5K
Nov 2, 2017 Nov 6, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 20.0 -24,818 -14.49% ✓ $1.8M
Sep 6, 2017 Oct 3, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 10.0 -20,393 -21.78% ✓ $1.2M
Sep 6, 2017 Sep 8, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 30.0 -4,607 -5.92% ✓ $276.4K
May 1, 2017 May 3, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 17.5 -15,000 -17.00% ✓ $810K
Apr 12, 2017 Apr 13, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 17.5 -13,065 -15.14% ✓ $658.8K
Feb 6, 2017 Feb 8, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 48.8 -727 -1.17% ✓ $31.4K
Feb 3, 2017 Feb 6, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -1,375 -2.24% ✓ $58.5K
Jan 17, 2017 Jan 18, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -1,625 -2.69% ✓ $66.1K
Jan 10, 2017 Jan 12, 2017 NEUROCRINE BIOSCIENCES INC Chief Business Development Off Sell 41.3 -1,250 -2.14% ✓ $54.2K